Kane Biotech股份在重型贸易中猛涨16.7%,在没有说明的理由的情况下上升到0.04科多巴元。 Kane Biotech shares surged 16.7% amid heavy trading, rising to C$0.04 with no stated reason.

Kane Biotech (CVE:KNE) 股份在星期三上升了16.7%,在达到0.05科多巴元的高位之后,以0.04科多巴元关闭,贸易量猛增,达到约150万科多巴股,比平均高出1 100%。 Kane Biotech (CVE:KNE) shares rose 16.7% on Wednesday, closing at C$0.04 after reaching a high of C$0.05, fueled by a surge in trading volume to around 1.5 million shares—over 1,100% above average. 该生物技术公司侧重于抗生物胶片技术,如用于伤口和耳朵感染的共活性+和分散性B,市场上限为586万科多巴元。 The biotech firm, focused on anti-biofilm technologies like coactiv+ and DispersinB for wound and ear infections, has a market cap of C$5.86 million. 目前其股票交易额超过50天和200天的移动平均数,负P/E为-0.44,低贝塔为0.29。 Its stock now trades above both its 50-day and 200-day moving averages, with a negative P/E of -0.44 and a low beta of 0.29. 债务与股本比率331.42表示净资产。 A debt-to-equity ratio of -331.42 indicates net assets. 没有列举集会的具体理由。 No specific reason for the rally was cited.